2025 Chronic Disease Diabetes Hypertension 
Today's Hospitalist
JUNE 7, 2025
THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. They presented a rapid clinical update Webinar in May 2025 hosted by the Society of Hospital Medicine.
GeriPal
JANUARY 16, 2025
If you’re in the outpatient setting, Tim, and you’re seeing somebody in clinic and you’re worried that they’re heading towards a path where, you know, their chronic diseases are getting worse, we may have to make some decisions. ABIM MOC credit will be offered to subscribers in November, 2025.
Expert insights. Personalized for you.
66 
Let's personalize your content